Here's the recent articles submitted by zenovel pharma
Articles By zenovel pharma
Clinical Trial Services For Generic Drug Development
Submitted as: zenovelpharma
Zenovel enables GCP-compliant setup and maintenance for CROs, focusing on vendor management, process optimization, QMS implementation, infrastructure development, and regulatory compliance, thereby improving efficiency, quality, and adherence to regulations.(read
entire article)
View : 56 Times
Category : Health
The Future Of Clinical Research In Generic Drug Development
Submitted as: zenovelpharma
Zenovel combines expertise and global reach to assist generic manufacturers in the evolving market. With extensive industry experience and a presence in key regions like India, the USA, Canada, and the EU, along with service to numerous countries, Zenovel is well-equipped for the future of generic drug development.(read
entire article)
View : 48 Times
Category : General
Preparing For Cphi Milan 2026: 7 Compliance Challenges Every Pharma Company Should Solve Before The Event
Submitted as: zenovelpharma
Share your priorities with bd@zenovel.com to schedule a meeting in Milan. Clear compliance foundations at CPHI enable a focus on key discussions regarding partnerships, innovation, and growth, rather than internal risks.(read
entire article)
View : 68 Times
Category : General
Risk-based Monitoring (rbm) In Clinical Trials: How Sponsors Can Improve Quality And Reduce Risk
Submitted as: zenovelpharma
In hindsight, RBM is now an established concept in clinical trials, with the focus shifting to its execution in 2026. The key challenge for sponsors is to implement RBM as a repeatable, defensible system that meets regulatory scrutiny by demonstrating effective monitoring actions. Successful sponsors integrate RBM into(read
entire article)
View : 34 Times
Category : General
Cro Setup & Upgradation In Brazil: Building A Gcp-compliant Clinical Research Organization
Submitted as: zenovelpharma
Data management and monitoring infrastructure must ensure that systems like EDC and safety databases are validated and secure, regardless of whether a CRO uses on-site monitoring, a risk-based model, or a hybrid approach. These systems must meet the requirements of ANVISA and any relevant international regulators.(read
entire article)
View : 41 Times
Category : General
Pk-stat Review In Bioequivalence Studies: Key Statistical Considerations For Regulatory Submissions
Submitted as: zenovelpharma
Drugs with an intra-subject CV over 30% often struggle to meet standard average bioequivalence criteria, even if they are therapeutically interchangeable. Both the FDA and EMA permit reference-scaled average bioequivalence (RSABE) methods that expand acceptance criteria based on the CV.(read
entire article)
View : 11 Times
Category : General
The Growing Importance Of Cro Partnerships In Pharmaceutical Manufacturing
By: zenovel pharma
There is also a critical need for alignment on quality and compliance; any discrepancies between a CRO's systems and the sponsor's standards could lead to regulatory issues.(read
entire article)
View : 11 Times
Category : General
Pic/s Inspection Readiness: How To Identify And Close Gmp Compliance Gaps Before An Inspection
By: zenovel pharma
The process aims to prioritize regulatory risks and systematically address the most significant gaps, ensuring documented effectiveness instead of superficially tackling issues before inspections.(read
entire article)
View : 10 Times
Category : General
